LOS ANGELES, June 9 /PRNewswire/ — For a patient suffering from Spinal Stenosis like Mike, back pain, leg pain and difficulty standing up becomes a forced way of life. Mike, a 51 year-old racket ball player and all around athlete reached a point where he could no longer stand up straight in the shower.
Luckily for Mike, Dr. Carl Lauryssen, a renowned spinal neurosurgeon and the director of spine research and development at the Olympia Medical Center Institute for Spinal Research in Los Angeles, California, was participating in a clinical trial that offered an alternative to the treatments of spinal stenosis. Mike was screened and had the procedure.
“When I first met Mike, he was suffering from pain and numbness in his left leg and in his back. He was frustrated by his constant pain and inability to play sports, which had been his love for most of his life,” explains Dr. Lauryssen. “I diagnosed him with Spinal Stenosis in L4 and L5 and he met the qualifications for an interspinous implant clinical trial which offered a minimally invasive treatment with a rapid recovery time.”
Lumbar Spinal Stenosis (LSS) is a very common cause of pain and immobility in middle age to elderly adults. Interspinous spacers act as a barrier and limit extension at symptomatic disc levels. This clinical trial aims to measure the effectiveness of inserting an interspinous spacer between the problematic discs and whether this procedure is effective at relieving the pressure on the spinal nerve and preserving mobility. If approved by the FDA, this treatment will serve as an alternative to more invasive surgical treatment such as decompressive laminectomy or surgical decompression with fusion.